Search Results - "Leontieva, Olga V"
-
1
Contact inhibition and high cell density deactivate the mammalian target of rapamycin pathway, thus suppressing the senescence program
Published in Proceedings of the National Academy of Sciences - PNAS (17-06-2014)“…During cell cycle arrest caused by contact inhibition (CI), cells do not undergo senescence, thus resuming proliferation after replating. The mechanism of…”
Get full text
Journal Article -
2
CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence: Duration of cell cycle arrest and MTOR activity determine geroconversion
Published in Cell cycle (Georgetown, Tex.) (15-09-2013)“…CDKN1A (p21) and CDKN2A (p16) inhibit CDK4/6, initiating senescence. According to our view on senescence, the role of p21 and p16 is to cause cell cycle…”
Get full text
Journal Article -
3
Hypoxia suppresses conversion from proliferative arrest to cellular senescence
Published in Proceedings of the National Academy of Sciences - PNAS (14-08-2012)“…Unlike reversible quiescence, cellular senescence is characterized by a large flat cell morphology, β-gal staining and irreversible loss of regenerative (i.e.,…”
Get full text
Journal Article -
4
Weak p53 permits senescence during cell cycle arrest
Published in Cell cycle (Georgetown, Tex.) (01-11-2010)“…Cell cycle arrest coupled with hyper-active mTOR leads to cellular senescence. While arresting cell cycle, high levels of p53 can inhibit mTOR (in some cell…”
Get full text
Journal Article -
5
M(o)TOR of pseudo-hypoxic state in aging: Rapamycin to the rescue
Published in Cell cycle (Georgetown, Tex.) (15-02-2014)“…A groundbreaking publication by Sinclair and coworkers has illuminated the pseudo-hypoxic state in aging and its reversibility. Remarkably, these data also fit…”
Get full text
Journal Article -
6
The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway
Published in Aging (Albany, NY.) (25-06-2010)“…Transient induction of p53 can cause reversible quiescence and irreversible senescence. Using nutlin-3a (a small molecule that activates p53 without causing…”
Get full text
Journal Article -
7
Exploring long-term protection of normal human fibroblasts and epithelial cells from chemotherapy in cell culture
Published in Oncotarget (01-03-2011)“…Killing of proliferating normal cells limits chemotherapy of cancer. Several strategies to selectively protect normal cells were previously suggested. Here we…”
Get full text
Journal Article -
8
Suppression of replicative senescence by rapamycin in rodent embryonic cells
Published in Cell cycle (Georgetown, Tex.) (15-06-2012)“…The TOR (target of rapamycin) pathway is involved in aging in diverse organisms from yeast to mammals. We have previously demonstrated in human and rodent…”
Get full text
Journal Article -
9
Hypoxia and gerosuppression: The mTOR saga continues
Published in Cell cycle (Georgetown, Tex.) (01-11-2012)“…Growth-promoting and nutrient/mitogen-sensing pathways such as mTOR convert p21- and p16-induced arrest into senescence (geroconversion). We have recently…”
Get full text
Journal Article -
10
Elimination of proliferating cells unmasks the shift from senescence to quiescence caused by rapamycin
Published in PloS one (11-10-2011)“…Depending on cellular context, p53-inducing agents (such as nutlin-3a) cause different outcomes including reversible quiescence and irreversible senescence…”
Get full text
Journal Article -
11
RNA-binding motif protein 35A is a novel tumor suppressor for colorectal cancer
Published in Cell cycle (Georgetown, Tex.) (01-02-2009)“…The frequent occurrence of inactivating gene mutations in tumors suggests a tumor suppressor function of the mutated gene. The RNA binding motif protein 35A…”
Get full text
Journal Article -
12
The reconstruction of evolutionary dynamics of processed pseudogenes indicates deep silencing of "retrobiome" in naked mole rat
Published in Proceedings of the National Academy of Sciences - PNAS (05-11-2024)“…Approximately half of mammalian genomes are occupied by retrotransposons, highly repetitive interspersed genetic elements expanded through the mechanism of…”
Get full text
Journal Article -
13
Gerosuppression by pan-mTOR inhibitors
Published in Aging (Albany, NY.) (30-12-2016)“…Rapamycin slows organismal aging and delays age-related diseases, extending lifespan in numerous species. In cells, rapamycin and other rapalogs such as…”
Get full text
Journal Article -
14
Weekly administration of rapamycin improves survival and biomarkers in obese male mice on high‐fat diet
Published in Aging cell (01-08-2014)“…Summary Recent discoveries have revealed the key role of mTOR (target of rapamycin) in aging. Furthermore, rapamycin extends lifespan in mice, especially in…”
Get full text
Journal Article -
15
DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence
Published in Aging (Albany, NY.) (01-12-2010)“…When the cell cycle is arrested, growth-promoting pathways such as mTOR (Target of Rapamycin) drive cellular senescence, characterized by cellular…”
Get full text
Journal Article -
16
Hyper-mitogenic drive coexists with mitotic incompetence in senescent cells
Published in Cell cycle (Georgetown, Tex.) (15-12-2012)“…When the cell cycle is arrested, even though growth-promoting pathways such as mTOR are still active, then cells senesce. For example, induction of either p21…”
Get full text
Journal Article -
17
Involvement of the ERK Signaling Cascade in Protein Kinase C-mediated Cell Cycle Arrest in Intestinal Epithelial Cells
Published in The Journal of biological chemistry (05-03-2004)“…We have reported previously that protein kinase C (PKC) signaling can mediate a program of cell cycle withdrawal in IEC-18 nontransformed intestinal crypt…”
Get full text
Journal Article -
18
Yeast-like chronological senescence in mammalian cells: phenomenon, mechanism and pharmacological suppression
Published in Aging (Albany, NY.) (01-11-2011)“…In yeast, chronological senescence (CS) is defined as loss of viability in stationary culture. Although its relevance to the organismal aging remained unclear,…”
Get full text
Journal Article -
19
Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program)
Published in Oncotarget (15-09-2015)“…In proliferating cells, mTOR is active and promotes cell growth. When the cell cycle is arrested, then mTOR converts reversible arrest to senescence…”
Get full text
Journal Article -
20
Tumor promoter-induced cellular senescence: cell cycle arrest followed by geroconversion
Published in Oncotarget (30-12-2014)“…Phorbol ester (PMA or TPA), a tumor promoter, can cause either proliferation or cell cycle arrest, depending on cellular context. For example, in SKBr3 breast…”
Get full text
Journal Article